BMJ Open February 2018 PMID 29439078

New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.

Richard Croker, Alex J Walker, Seb Bacon, Helen J Curtis, Lisa French, Ben Goldacre

Mentions

6
Peak: 3 in Nov 2024
across 4 sources since Jun 2020

Extended reach

3,230
potential audience

Total likes

0

Video views

306

Mentions per month

Jun 2020 – Nov 2024

Where it's discussed

  • YouTube3 videos
  • X / Twitter1 posts
  • News1 articles
  • Blogs1 articles

AI synopsis

What people are saying

The discussions reflect a balanced view, with users appreciating the innovative focus on reducing 'price per unit' and citing examples like savings in glucose testing reagents and medications such as fluticasone. The tone suggests cautious optimism, recognizing the potential for substantial cost reductions without dismissing practical challenges.

AgreementModerate agreement

Most posts seem to agree that the proposed method offers a valuable new approach to cost savings, highlighting the benefits over traditional strategies.

InterestModerate interest

Participants display some curiosity about the methodology and implications, but overall level of engagement remains moderate.

EngagementModerate engagement

Discussions include mention of specific drug savings and potential policy impacts, indicating a moderate level of detailed involvement.

ImpactModerate impact

There is a general sense that this approach could positively influence NHS prescribing practices, suggesting moderate to high significance.

Abstract in brief

  • This study introduces a new way to identify and achieve significant cost savings in NHS prescribing by analyzing national variations in drug prices and comparing these with savings from generic switching.
  • The researchers used NHS digital data from 2015-2016 to calculate potential savings based on reducing the price per unit of drugs and found a theoretical maximum saving of 410 million pounds annually, with about half deemed practically achievable.
  • The largest savings were identified in drugs like glucose testing reagents, fluticasone, and venlafaxine, and this method appears to be more effective than traditional generic switching strategies for reducing healthcare costs.]

Top posts

Most liked on X and Bluesky
bioRxiv Published
@biorxiv_pubd · X

A New Mechanism To Identify Cost Savings in NHS Prescribing: Minimising �Price-Per-Unit� published as: https://t.co/Wwtzpf9wEv @BMJ_Open #biorxiv

Jun 2, 2020 · 2,905 followers View post →

All mentions

bioRxiv Published
@biorxiv_pubd · X

A New Mechanism To Identify Cost Savings in NHS Prescribing: Minimising �Price-Per-Unit� published as: https://t.co/Wwtzpf9wEv @BMJ_Open #biorxiv

Jun 2, 2020 · 2,905 followers View post →
NHS Value-Based Healthcare Report | PDF | Health Care | National ...
News

BMJ Open. 2018;8:e019643. doi:10.1136/bmjopen-2017-019643 10 Gray M. Value based healthcare. BMJ 2017;356:j437. 11 EUPIA. The Value of Health: Improving ...

Dec 17, 2025 View →
Defining Value-based Healthcare in the NHS
Blogs

BMJ Open. 2018;8:e019643. doi:10.1136/bmjopen-2017-019643. 10 Gray M. Value based healthcare. BMJ 2017;356:j437. 11 EUPIA. The Value of Health: Improving ...

Dec 17, 2025 View →